Navigation Links
QLT announces first quarter 2008 Visudyne(R) sales
Date:4/21/2008

VANCOUVER, April 21 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ:QLTI; TSX:QLT) today reported that Novartis AG announced global sales of QLT's Visudyne(R) (verteporfin) product of US$36.5 million for the quarter ended March 31, 2008. This represents a decrease of 40.4% over sales in the first quarter of 2007. Sales in the U.S. were $9.3 million, up 10.6% from the prior-year first quarter, while sales outside the U.S. were $27.2 million, down 48.5% from the prior year. The drop in Visudyne sales was primarily due to the approval and reimbursement in Europe of alternative therapeutics for age-related macular degeneration.

QLT will release its full financial results on Friday, April 25, 2008, at 7:30 a.m. ET.

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne and Eligard(R) and future product opportunities. For more information, visit our web site at http://www.qltinc.com.

Conference call information

QLT Inc. will hold an investor conference call to discuss first quarter 2008 results on Friday, April 25 at 8:30 a.m. ET (5:30 a.m. PT). The call will be broadcast live via the Internet at http://www.qltinc.com. To participate on the call, please dial 1-800-319-4610 (North America) or 604-638-5340 (International) before 8:30 a.m. ET. A replay of the call will be available via the Internet and also via telephone at 1-800-319-6413 (North America) or 604-638-9010 (International), access code 7157, followed by the "#" sign.

A full explanation of how QLT determines and recognizes re
'/>"/>

SOURCE QLT Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Breckenridge Announces Approval of Generic Activella(R)
2. Accenx Technologies Announces New Leadership in Sales and Marketing Division
3. VNUS Medical Technologies, Inc. Announces the Hiring of Don Todd as Vice President of Marketing
4. CardiacAssist, Inc. Announces Five New TandemHeart Centers of Excellence
5. HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility
6. GHX Announces 2008 Best In Class Award Winners
7. AtriCure Announces Web Cast and Conference Call of First Quarter 2008 Financial Results
8. Huifeng Bio-Pharmaceutical (HFGB) Announces Participation in the 59th PHARMCHINA Expo
9. Zimmer Announces New Compliance Model
10. The Alliance for Lupus Research Announces 2008 Grantees
11. TeamStaff, Inc. Announces Results From Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 A ... scandal deviating from the typical nip slip or scathing ... movie industry is dawning the streets of Hollywood as ... questions about drug addiction and substance abuse in Hollywood. ... constructed to take a political stance on the travails ...
(Date:3/2/2015)... FL (PRWEB) March 02, 2015 While ... with Title VI of the Civil Rights Act, the ... and hearing loss are bringing light to the value ... statistics reveal that nearly 1 in 20 U.S. children ... in 10 in some major cities.(1) Stratus Video ...
(Date:3/2/2015)... 2015 Robins & Morton Celebrates Women ... Women in Construction Week (March 1-7, sponsored by the ... National Women’s History Month, Robins & Morton is recognizing ... company and the construction industry as a whole. From ... dozens of roles in between, each woman has a ...
(Date:3/2/2015)... 2015 Over the last five years ... vendors seeking to expand their geographic presence and achieve ... to reach $6.2 billion by 2019 at CAGR of ... the U.S. and Canada and a major part of ... regions such as Asia-Pacific including China and India, Latin ...
(Date:3/2/2015)... March 02, 2015 Dinner preparation ... thanks to the success of DinnerDork , ... easy and delicious for thousands of busy customers. ... feedback by expanding to offer a total of ... features seasonally appropriate classic recipes and comfort foods; ...
Breaking Medicine News(10 mins):Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Robins & Morton Recognizes Women In Construction 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3
... Price of Diabetes Prevention Far Less ... , BETHESDA, Md., Aug. 18 The ... has been misconstrued during recent health care reform discussions, according ... professional organization of doctors of podiatric medicine (DPMs), also known ...
... , WASHINGTON, Aug. 18 300,000 American women with ... US had adopted a British-style, government-run health care system. This ... Oncology, appears in a TV ad launched today by The Independent ... women. The 60-second spot highlights the deadly risks to women ...
... , , ... cell volume measurement in the flexographic printing industry, will be ... is a highly versatile, lightweight instrument that is extremely accurate ... The MicroDynamics QC line of inspection microscopes have a reputation ...
... Institutes of Health have found that the activity of a ... aggressive brain cancer called glioblastoma multiforme (GBM). In a move ... can block this activity and reduce the spreading of GBM ... lethal form of brain cancer, with about half of patients ...
... Aug. 18 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) ... pleased to report that its clinical trial is currently being ... September (Approx 60 days). The company expects the manufacturing license ... , H1N1 (referred to as "swine flu" early on) is ...
... , LOS ANGELES, Aug. 18 On THURSDAY, ... organization committed to improving the quality of life for Latino children ... gala, " EL SUENO DE ESPERANZA " at the Hollywood Palladium. ... children and families, while at the same time raise funds for ...
Cached Medicine News:Health News:American Podiatric Medical Association Corrects President's Misstatement on Foot Amputation Costs 2Health News:Women Speak Out Against Government Takeover of Health Care 2Health News:Women Speak Out Against Government Takeover of Health Care 3Health News:NIH researchers identify key factor that stimulates brain cancer cells to spread 2Health News:NIH researchers identify key factor that stimulates brain cancer cells to spread 3Health News:Hard To Treat Diseases (HTDS.PK) H1N1 Swine Flu Clinical Trial 2Health News:Hard To Treat Diseases (HTDS.PK) H1N1 Swine Flu Clinical Trial 3Health News:Eva Longoria Parker and George Lopez Return to Host 9th Annual PADRES' Contra El Cancer's 'EL SUENO DE ESPERANZA' Gala 2Health News:Eva Longoria Parker and George Lopez Return to Host 9th Annual PADRES' Contra El Cancer's 'EL SUENO DE ESPERANZA' Gala 3Health News:Eva Longoria Parker and George Lopez Return to Host 9th Annual PADRES' Contra El Cancer's 'EL SUENO DE ESPERANZA' Gala 4
(Date:3/2/2015)... CUPERTINO, Calif., March 2, 2015  DURECT Corporation (Nasdaq: ... the three months ended December 31, 2014. Total revenues ... 31, 2014 and for the three months ended December ... three months ended December 31, 2014 as compared to ... period in 2013.Total revenues were $19.4 million and net ...
(Date:3/2/2015)... , March 2, 2015 When someone gets ... head to a primary care physician or an urgent ... majority of the healthcare provided by doctors and medical ... works, but it,s not ideal in every circumstance. Though ... actually locations where occupants have higher chances of contracting ...
(Date:3/2/2015)... March 2, 2015  Champions Oncology, Inc. (OTC-PINK: CSBR), ... solutions and services to personalize the development and use ... on the $2 million convertible promissory notes with two ... Dr. David Sidransky , chairman ... benefit from the confidence and commitment of our two ...
Breaking Medicine Technology:DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 3DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 4DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 5DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 6DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 7DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 8DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 9DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 10DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 11DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 12House Call Medicine Helps Patients Receive Treatment While Avoiding the Hassles and Potential Risks of an Urgent Care Facility 2Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3
... risk of cardiovascular hospitalization or death by 24 percent ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New ... the ATHENA trial was published in the New England ... in addition to standard therapy, significantly reduced the risk ...
... treatment decisionsANN ARBOR, Mich., Feb. 11 Researchers from ... have identified a panel of small molecules, or metabolites, ... lead to a simple test that would help doctors ... immediate, aggressive treatment.Results of the study appear in the ...
Cached Medicine Technology:New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 2Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: